Literature DB >> 19123313

Phage type and antimicrobial susceptibility of Salmonella enterica serovar Enteritidis from food-producing animals in Japan between 1976 and 2004.

Tetsuo Asai1, Kazuki Harada, Akemi Kojima, Toshiya Sameshima, Toshio Takahashi, Masato Akiba, Muneo Nakazawa, Hidemasa Izumiya, Jun Terajima, Haruo Watanbe.   

Abstract

A total of 56 isolates of Salmonella enterica serovar Enteritidis, including 38 isolates from poultry, 16 from cattle and two from pigs, collected between 1976 and 2004, were subjected to bacteriophage typing and antimicrobial susceptibility testing. Phage type (PT) 8 was predominant in bovine isolates, whereas PT1 and PT4 were predominant in poultry isolates. Resistance was found for 8 of 11 antimicrobials tested, at the following rates: 46.4% for dihydrostreptomycin followed by ampicillin and oxytetracycline (both 8.9%).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19123313

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  3 in total

1.  Multi locus variable-number tandem repeat (MLVA) typing tools improved the surveillance of Salmonella enteritidis: a 6 years retrospective study.

Authors:  Sophie Bertrand; Guillaume De Lamine de Bex; Christa Wildemauwe; Octavie Lunguya; Marie France Phoba; Benedikt Ley; Jan Jacobs; Raymond Vanhoof; Wesley Mattheus
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

2.  Molecular typing of Salmonella enterica serovar Enteritidis isolates from food-producing animals in Japan by multilocus variable-number tandem repeat analysis: evidence of clonal dissemination and replacement.

Authors:  Ayumi Kobayashi; Sayaka Takahashi; Masaaki Ono; Kiyoshi Tanaka; Masato Kishima; Masato Akiba; Ikuo Uchida
Journal:  Acta Vet Scand       Date:  2014-05-13       Impact factor: 1.695

3.  Comparative genomics identifies distinct lineages of S. Enteritidis from Queensland, Australia.

Authors:  Rikki M A Graham; Lester Hiley; Irani U Rathnayake; Amy V Jennison
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.